Your browser doesn't support javascript.
loading
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome.
Capaci, Valeria; Bascetta, Lorenzo; Fantuz, Marco; Beznoussenko, Galina V; Sommaggio, Roberta; Cancila, Valeria; Bisso, Andrea; Campaner, Elena; Mironov, Alexander A; Wisniewski, Jacek R; Ulloa Severino, Luisa; Scaini, Denis; Bossi, Fleur; Lees, Jodi; Alon, Noa; Brunga, Ledia; Malkin, David; Piazza, Silvano; Collavin, Licio; Rosato, Antonio; Bicciato, Silvio; Tripodo, Claudio; Mantovani, Fiamma; Del Sal, Giannino.
Afiliação
  • Capaci V; Laboratorio Nazionale CIB (LNCIB), 34149, Trieste, Italy.
  • Bascetta L; Laboratorio Nazionale CIB (LNCIB), 34149, Trieste, Italy.
  • Fantuz M; International School for Advanced Studies (SISSA), 34146, Trieste, Italy.
  • Beznoussenko GV; Laboratorio Nazionale CIB (LNCIB), 34149, Trieste, Italy.
  • Sommaggio R; International School for Advanced Studies (SISSA), 34146, Trieste, Italy.
  • Cancila V; Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139, Milan, Italy.
  • Bisso A; Veneto Institute of Oncology IOV-IRCCS, 35128, Padua, Italy.
  • Campaner E; Tumor Immunology Unit, Department of Health Science, Human Pathology Section, University of Palermo, School of Medicine, 90133, Palermo, Italy.
  • Mironov AA; Laboratorio Nazionale CIB (LNCIB), 34149, Trieste, Italy.
  • Wisniewski JR; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20141, Milan, Italy.
  • Ulloa Severino L; Laboratorio Nazionale CIB (LNCIB), 34149, Trieste, Italy.
  • Scaini D; Dipartimento di Scienze della Vita, Università degli Studi di Trieste, 34127, Trieste, Italy.
  • Bossi F; Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139, Milan, Italy.
  • Lees J; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 85152, Martinsried, Germany.
  • Alon N; Dipartimento di Scienze della Vita, Università degli Studi di Trieste, 34127, Trieste, Italy.
  • Brunga L; International School for Advanced Studies (SISSA), 34146, Trieste, Italy.
  • Malkin D; Dipartimento di Scienze della Vita, Università degli Studi di Trieste, 34127, Trieste, Italy.
  • Piazza S; Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
  • Collavin L; Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
  • Rosato A; Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
  • Bicciato S; Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
  • Tripodo C; Department of Pediatrics, University of Toronto, Toronto, ON, Canada.
  • Mantovani F; Laboratorio Nazionale CIB (LNCIB), 34149, Trieste, Italy.
  • Del Sal G; Laboratorio Nazionale CIB (LNCIB), 34149, Trieste, Italy.
Nat Commun ; 11(1): 3945, 2020 08 07.
Article em En | MEDLINE | ID: mdl-32770028
ABSTRACT
TP53 missense mutations leading to the expression of mutant p53 oncoproteins are frequent driver events during tumorigenesis. p53 mutants promote tumor growth, metastasis and chemoresistance by affecting fundamental cellular pathways and functions. Here, we demonstrate that p53 mutants modify structure and function of the Golgi apparatus, culminating in the increased release of a pro-malignant secretome by tumor cells and primary fibroblasts from patients with Li-Fraumeni cancer predisposition syndrome. Mechanistically, interacting with the hypoxia responsive factor HIF1α, mutant p53 induces the expression of miR-30d, which in turn causes tubulo-vesiculation of the Golgi apparatus, leading to enhanced vesicular trafficking and secretion. The mut-p53/HIF1α/miR-30d axis potentiates the release of soluble factors and the deposition and remodeling of the ECM, affecting mechano-signaling and stromal cells activation within the tumor microenvironment, thereby enhancing tumor growth and metastatic colonization.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Transformação Celular Neoplásica / Proteína Supressora de Tumor p53 / Síndrome de Li-Fraumeni / MicroRNAs / Complexo de Golgi Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Commun Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Transformação Celular Neoplásica / Proteína Supressora de Tumor p53 / Síndrome de Li-Fraumeni / MicroRNAs / Complexo de Golgi Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Commun Ano de publicação: 2020 Tipo de documento: Article